sgn-2ff
Showing 1 - 1 of 1
NSCLC, Carcinoma, Renal Cell, Breast Tumors Trial in United States (SGN-2FF, pembrolizumab)
Terminated
- Carcinoma, Non-Small-Cell Lung
- +7 more
- SGN-2FF
- pembrolizumab
-
Birmingham, Alabama
- +10 more
Jul 17, 2019